1. Home
  2. RGEN vs MC Comparison

RGEN vs MC Comparison

Compare RGEN & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • MC
  • Stock Information
  • Founded
  • RGEN 1981
  • MC 2007
  • Country
  • RGEN United States
  • MC United States
  • Employees
  • RGEN N/A
  • MC N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • MC Investment Managers
  • Sector
  • RGEN Health Care
  • MC Finance
  • Exchange
  • RGEN Nasdaq
  • MC Nasdaq
  • Market Cap
  • RGEN 6.5B
  • MC 5.5B
  • IPO Year
  • RGEN N/A
  • MC 2014
  • Fundamental
  • Price
  • RGEN $152.80
  • MC $67.68
  • Analyst Decision
  • RGEN Buy
  • MC Buy
  • Analyst Count
  • RGEN 11
  • MC 8
  • Target Price
  • RGEN $167.90
  • MC $71.86
  • AVG Volume (30 Days)
  • RGEN 972.1K
  • MC 691.0K
  • Earning Date
  • RGEN 10-28-2025
  • MC 10-29-2025
  • Dividend Yield
  • RGEN N/A
  • MC 3.84%
  • EPS Growth
  • RGEN N/A
  • MC 1309.15
  • EPS
  • RGEN N/A
  • MC 2.67
  • Revenue
  • RGEN $673,956,000.00
  • MC $1,384,443,000.00
  • Revenue This Year
  • RGEN $16.77
  • MC $25.99
  • Revenue Next Year
  • RGEN $13.79
  • MC $17.08
  • P/E Ratio
  • RGEN N/A
  • MC $25.35
  • Revenue Growth
  • RGEN 8.73
  • MC 42.85
  • 52 Week Low
  • RGEN $102.97
  • MC $47.00
  • 52 Week High
  • RGEN $182.52
  • MC $82.89
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 65.63
  • MC 44.73
  • Support Level
  • RGEN $143.47
  • MC $63.10
  • Resistance Level
  • RGEN $157.03
  • MC $69.15
  • Average True Range (ATR)
  • RGEN 6.17
  • MC 2.19
  • MACD
  • RGEN 0.64
  • MC -0.03
  • Stochastic Oscillator
  • RGEN 87.20
  • MC 46.12

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Share on Social Networks: